Literature DB >> 26160870

Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study.

Mathieu S Bolhuis1, Simon Tiberi2, Giovanni Sotgiu3, Saverio De Lorenzo4, Jos G W Kosterink5, Tjip S van der Werf6, Giovanni Battista Migliori7, Jan-Willem C Alffenaar8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26160870     DOI： 10.1183/13993003.00606-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  15 in total

1.  Comparison of In Vitro Activity and MIC Distributions between the Novel Oxazolidinone Delpazolid and Linezolid against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis in China.

Authors:  Zhaojing Zong; Wei Jing; Jin Shi; Shu'an Wen; Tingting Zhang; Fengmin Huo; Yuanyuan Shang; Qian Liang; Hairong Huang; Yu Pang
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

2.  Linezolid use for drug-resistant tuberculosis in Georgia: a retrospective cohort study.

Authors:  L Mikiashvili; M Kipiani; M C Schechter; Z Avaliani; N Kiria; R R Kempker
Journal:  Int J Tuberc Lung Dis       Date:  2020-04-01       Impact factor: 2.373

Review 3.  Enhancement of lung levels of antibiotics by ambroxol and bromhexine.

Authors:  Vojo Deretic; Graham S Timmins
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-02-07       Impact factor: 4.481

4.  Linezolid toxicity in patients with drug-resistant tuberculosis: a prospective cohort study.

Authors:  Sean Wasserman; James C M Brust; Mahmoud T Abdelwahab; Francesca Little; Paolo Denti; Lubbe Wiesner; Neel R Gandhi; Graeme Meintjes; Gary Maartens
Journal:  J Antimicrob Chemother       Date:  2022-03-31       Impact factor: 5.758

Review 5.  Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs.

Authors:  Johanna Kuhlin; Marieke G G Sturkenboom; Samiksha Ghimire; Ioana Margineanu; Simone H J van den Elsen; Noviana Simbar; Onno W Akkerman; Erwin M Jongedijk; Remco A Koster; Judith Bruchfeld; Daan J Touw; Jan-Willem C Alffenaar
Journal:  Clin Mass Spectrom       Date:  2018-10-19

6.  Linezolid for drug-resistant pulmonary tuberculosis.

Authors:  Bhagteshwar Singh; Derek Cocker; Hannah Ryan; Derek J Sloan
Journal:  Cochrane Database Syst Rev       Date:  2019-03-20

Review 7.  Pharmacologic management of Mycobacterium ulcerans infection.

Authors:  Tjip S Van Der Werf; Yves T Barogui; Paul J Converse; Richard O Phillips; Ymkje Stienstra
Journal:  Expert Rev Clin Pharmacol       Date:  2020-04-20       Impact factor: 4.108

8.  Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France.

Authors:  Marie Jaspard; Nathalie Butel; Najoua El Helali; Dhiba Marigot-Outtandy; Helene Guillot; Gilles Peytavin; Nicolas Veziris; Bahram Bodaghi; Philippe Flandre; Gregoire Petitjean; Eric Caumes; Valerie Pourcher
Journal:  Emerg Infect Dis       Date:  2020-08       Impact factor: 6.883

Review 9.  Management of multidrug-resistant TB: novel treatments and their expansion to low resource settings.

Authors:  Derek J Sloan; Joseph M Lewis
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-03       Impact factor: 2.184

10.  Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation.

Authors:  James Millard; Henry Pertinez; Laura Bonnett; Eva Maria Hodel; Véronique Dartois; John L Johnson; Maxine Caws; Simon Tiberi; Mathieu Bolhuis; Jan-Willem C Alffenaar; Geraint Davies; Derek J Sloan
Journal:  J Antimicrob Chemother       Date:  2018-07-01       Impact factor: 5.790
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.